CAS 39840-37-4

D-Lyxosylamine

Description:

D-Lyxosylamine is an amino sugar derivative characterized by its structural features, which include an amine group attached to a sugar backbone. It is a stereoisomer of lyxose, specifically the D-form, which means it has a specific spatial arrangement of its atoms that influences its biological activity and reactivity. This compound is typically white to off-white in appearance and is soluble in water due to the presence of hydroxyl groups, which facilitate hydrogen bonding. D-Lyxosylamine is of interest in various fields, including biochemistry and medicinal chemistry, as it may play a role in glycosylation processes and can serve as a building block for more complex molecules. Its reactivity is influenced by the functional groups present, allowing it to participate in various chemical reactions, including those involving nucleophilic substitution. As with many amino sugars, it may exhibit biological activity, potentially impacting cellular processes or serving as a precursor for the synthesis of biologically relevant compounds.

Formula: C₆H₁₃NO₄

InChI: InChI=1/C5H11NO4/c6-5-4(9)3(8)2(7)1-10-5/h2-5,7-9H,1,6H2

SMILES: C1C(C(C(C(N)O1)O)O)O

Synonyms:

• Pentopyranosylamine
• D-(-)-LYXOSYLAMINE
• D-LYXOSYLAMINE
• Lyxosylamine
• (2R,3R,4R)-5-Aminopentane-1,2,3,4-tetraol
• 1-AMINO-1-DEOXY-D-LYXOSE
• D -(-)-LYXOSYLAMINE CRYSTALLINE

D-Lyxosylamine

CAS: 39840-37-4

Molecular weight: 149.15

Ref: 7W-GC2232

D-Lyxosylamine

CAS: 39840-37-4

D-Lyxosylamine is a drug that has been shown to have anticancer activity against leishmania species. It inhibits the growth of the parasite by binding to the lectin, sialic, and glycoconjugates on the surface of cells. This inhibition leads to a blockage in the transport of glucose and amino acids, which are essential for cell growth and replication. D-Lyxosylamine has also been shown to have anti-leukemic effects, which may be due to its ability to kill lymphocytic leukemia cells. The drug was administered orally in a clinical trial with human volunteers in order to test its effectiveness against Leishmania major infections. D-Lyxosylamine administered at 50mg/kg/day for 28 days had no significant effect on Leishmania major infection rates.

Formula: C₅H₁₁NO₄

Purity: Min. 95%

Color and Shape: White Powder

Molecular weight: 149.1 g/mol

Ref: 3D-ML04961